Development and Characterisation of Valsartan Immediate Release Dosage Form Using Solubility Enhancement Technique
The objective of the present investigation is to improve the solubility of valsartan and prepare immediate release tablets.
Saved in:
Main Authors: | , , |
---|---|
Format: | Book |
Published: |
Sciendo,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_dff7919a714b47f59bc035b34b83eb8d | ||
042 | |a dc | ||
100 | 1 | 0 | |a Saripilli R. |e author |
700 | 1 | 0 | |a Teella P. |e author |
700 | 1 | 0 | |a Nataraj Kalakonda S. |e author |
245 | 0 | 0 | |a Development and Characterisation of Valsartan Immediate Release Dosage Form Using Solubility Enhancement Technique |
260 | |b Sciendo, |c 2024-06-01T00:00:00Z. | ||
500 | |a 2453-6725 | ||
500 | |a 10.2478/afpuc-2024-0005 | ||
520 | |a The objective of the present investigation is to improve the solubility of valsartan and prepare immediate release tablets. | ||
546 | |a EN | ||
690 | |a immediate release tablets | ||
690 | |a valsartan | ||
690 | |a β-cyclodextrin | ||
690 | |a poly vinyl pyrrolidone k30 | ||
690 | |a poloxamer 188 | ||
690 | |a physical mixture | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n European Pharmaceutical Journal, Vol 71, Iss 1, Pp 32-42 (2024) | |
787 | 0 | |n https://doi.org/10.2478/afpuc-2024-0005 | |
787 | 0 | |n https://doaj.org/toc/2453-6725 | |
856 | 4 | 1 | |u https://doaj.org/article/dff7919a714b47f59bc035b34b83eb8d |z Connect to this object online. |